Tags

Type your tag names separated by a space and hit enter

Concentration and distribution of ubiquinone (coenzyme Q), the endogenous lipid antioxidant, in the rat lens: effect of treatment with simvastatin.
Mol Vis. 2005 Aug 10; 11:594-602.MV

Abstract

PURPOSE

Ubiquinone (Ub) is the only known endogenously synthesized lipid soluble antioxidant. It is synthesized from intermediates in the cholesterol metabolic pathway. Our goal was to identify the Ubs and determine the concentration and distribution of Ubs in the rat lens and the effect of treatment with simvastatin, a cholesterol synthesis inhibitor, on lens levels.

METHODS

Intact lenses and separated lens fractions from young rats were homogenized in organic solvents, the Ubs recovered, and identified by HPLC analysis. Rats were fed Ub-10 to determine effects of supplementation on tissue levels. Sprague-Dawley (SD) and Chbb:Thom (CT) rats were treated with simvastatin, an inducer of cataracts in CT rats, to determine its effects on lens Ubs.

RESULTS

Ubiquinone-9 (9 isoprenes in its hydrocarbon tail) was the main Ub in the rat lens. The intact lens contained about 3.0 microg Ub/g lens wet weight of which 80-90% was Ub-9 and the remainder Ub-10. No reduced Ubs were detected. Although the epithelial fraction contained the highest Ub concentration (about 8 microg/g), the cortex and nucleus combined accounted for about 90% of the lens' total content. Dietary supplementation with Ub-10 markedly increased the Ub-10 concentration in liver but not lens. Treatment with simvastatin decreased lens Ubs of both SD and CT rats by about 20%.

CONCLUSIONS

The abundance of mitochondria in lens epithelium likely accounted for its high level of Ubs; but, finding most of the lens' total Ub in the cortex plus nucleus also suggests roles in maintaining the fiber cell membrane. The decrease in lens Ubs caused by simvastatin is interpreted to reflect a response to drug induced cellular stress rather than to inhibition of the cholesterol synthesis pathway.

Authors+Show Affiliations

Department of Biochemistry, Kirksville College of Osteopathic Medicine, Kirksville, MO 63501, USA. rcenedella@atsu.eduNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, P.H.S.

Language

eng

PubMed ID

16110301

Citation

Cenedella, Richard J., et al. "Concentration and Distribution of Ubiquinone (coenzyme Q), the Endogenous Lipid Antioxidant, in the Rat Lens: Effect of Treatment With Simvastatin." Molecular Vision, vol. 11, 2005, pp. 594-602.
Cenedella RJ, Neely AR, Sexton P. Concentration and distribution of ubiquinone (coenzyme Q), the endogenous lipid antioxidant, in the rat lens: effect of treatment with simvastatin. Mol Vis. 2005;11:594-602.
Cenedella, R. J., Neely, A. R., & Sexton, P. (2005). Concentration and distribution of ubiquinone (coenzyme Q), the endogenous lipid antioxidant, in the rat lens: effect of treatment with simvastatin. Molecular Vision, 11, 594-602.
Cenedella RJ, Neely AR, Sexton P. Concentration and Distribution of Ubiquinone (coenzyme Q), the Endogenous Lipid Antioxidant, in the Rat Lens: Effect of Treatment With Simvastatin. Mol Vis. 2005 Aug 10;11:594-602. PubMed PMID: 16110301.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Concentration and distribution of ubiquinone (coenzyme Q), the endogenous lipid antioxidant, in the rat lens: effect of treatment with simvastatin. AU - Cenedella,Richard J, AU - Neely,Amanda R, AU - Sexton,Patricia, Y1 - 2005/08/10/ PY - 2005/8/20/pubmed PY - 2006/4/14/medline PY - 2005/8/20/entrez SP - 594 EP - 602 JF - Molecular vision JO - Mol Vis VL - 11 N2 - PURPOSE: Ubiquinone (Ub) is the only known endogenously synthesized lipid soluble antioxidant. It is synthesized from intermediates in the cholesterol metabolic pathway. Our goal was to identify the Ubs and determine the concentration and distribution of Ubs in the rat lens and the effect of treatment with simvastatin, a cholesterol synthesis inhibitor, on lens levels. METHODS: Intact lenses and separated lens fractions from young rats were homogenized in organic solvents, the Ubs recovered, and identified by HPLC analysis. Rats were fed Ub-10 to determine effects of supplementation on tissue levels. Sprague-Dawley (SD) and Chbb:Thom (CT) rats were treated with simvastatin, an inducer of cataracts in CT rats, to determine its effects on lens Ubs. RESULTS: Ubiquinone-9 (9 isoprenes in its hydrocarbon tail) was the main Ub in the rat lens. The intact lens contained about 3.0 microg Ub/g lens wet weight of which 80-90% was Ub-9 and the remainder Ub-10. No reduced Ubs were detected. Although the epithelial fraction contained the highest Ub concentration (about 8 microg/g), the cortex and nucleus combined accounted for about 90% of the lens' total content. Dietary supplementation with Ub-10 markedly increased the Ub-10 concentration in liver but not lens. Treatment with simvastatin decreased lens Ubs of both SD and CT rats by about 20%. CONCLUSIONS: The abundance of mitochondria in lens epithelium likely accounted for its high level of Ubs; but, finding most of the lens' total Ub in the cortex plus nucleus also suggests roles in maintaining the fiber cell membrane. The decrease in lens Ubs caused by simvastatin is interpreted to reflect a response to drug induced cellular stress rather than to inhibition of the cholesterol synthesis pathway. SN - 1090-0535 UR - https://www.unboundmedicine.com/medline/citation/16110301/Concentration_and_distribution_of_ubiquinone__coenzyme_Q__the_endogenous_lipid_antioxidant_in_the_rat_lens:_effect_of_treatment_with_simvastatin_ L2 - http://www.molvis.org/molvis/v11/a70/ DB - PRIME DP - Unbound Medicine ER -